Search Results
GFR Decline as a Surrogate Endpoint for Progression of Chronic Kidney Disease
Emerging data from EMPA-KIDNEY study
Available Kidney Measures, Their Value for Detecting CKD, and Discriminating Stage and Prognosis
Lowering GFR to Protect GFR!
SGLT2i in different patient groups: effect on CKD progression | Natalie Staplin, PhD
Evolving therapies to treat chronic kidney disease - UBC and BCR Province Wide Rounds 10.28.2022
Webinar Wednesdays - Total kidney volume and PKD
Challenges in Adjudicating Endpoints for Kidney Disease
The London Kidney Network: Identifying, Coding and Managing Chronic Kidney Disease (9 March 2023)
Professor Christoph Wanner - Renoprotective effects of SGLT2 inhibitors
2021 PKD Regulatory Summit: Lessons Learned Over Nearly Two Decades of CKD-EPI
Update: Surrogacy, IVF, Kidney Disease
